NOLA-B.ST
NOLA-B.ST
SE0015962477
Nolato AB ser. B
Loading chart...

Company Profile

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and dropper bottles. It also provides thermal heating pads, gap fillers, and paste under the Compatherm brand; Autolys M products, deep well plates, microtubes, PCR/qPCR products, pipettes and slim-line pipette tips, vial HP, and quality grades under the TreffLab by Nolato; and electromagnetic compatibility (EMC) products, including Compashield molded and extruded electromagnetic interference (EMI) shielding gaskets, Trishield, and MIL SPEC EMI shielding products. In addition, the company offers laboratory products, such as boxes with integrated lids; containers with hinged lids; sampling and transport tubes; spoons and cups; disposable tubes and containers; test tubes and ergonomic caps; and containers, vials, and slide tubes with push on lids. Further, it provides injection molding of plastic and silicone, injection blow molding, scientific and ceramic injection molding, dip and compression molding, and micro molding; extrusion and silicone sponge extrusion technologies; thermal management; decoration and cutting technologies; cleanroom production; assembly solutions; design and virtual prototyping solutions; and tool manufacturing. It serves medical technology, pharmaceutical, consumer electronics, telecom, automotive, hygiene, and other industrial sectors. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was founded in 1938 and is headquartered in Torekov, Sweden.

Related stocks

EKTA-B.ST
EKTA-B.ST • Sweden
Elekta AB ser. B
54.45 SEK
2.08B USD 1Y +8%
MCAP.ST
MCAP.ST • Sweden
MedCap AB
515 SEK
771.71M USD 1Y -13%
DRW8.DE
DRW8.DE • Germany
DRAEGERWERK ST.A.O.N.
90 EUR
1.89B USD 1Y +69%
NVCR
NVCR • Switzerland
NovoCure Limited
14.58 USD
1.7B USD 1Y -0.9%
ELN.MI
ELN.MI • Italy
EL.EN.
16.05 EUR
1.44B USD 1Y +34.9%
VITR.ST
VITR.ST • Sweden
Vitrolife AB
95.6 SEK
1.3B USD 1Y -33.5%
KURN.SW
KURN.SW • Switzerland
KUROS N
18.35 CHF
877.11M USD 1Y -38.4%
SECT-B.ST
SECT-B.ST • Sweden
SECTRA AB ser B
310.2 SEK
5.98B USD 1Y -1.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
34.9% p.a.
Max Drawdown (5Y)
-66.2%
Sharpe Ratio (5Y)
-0.39
Beta Factor
0.75
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (34.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -66.2% in the extended horizon.
ende